GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Gross Profit

Clearmind Medicine (Clearmind Medicine) Gross Profit : $0.00 Mil (TTM As of Apr. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Gross Profit?

Clearmind Medicine's gross profit for the three months ended in Apr. 2024 was $0.00 Mil. Clearmind Medicine's gross profit for the trailing twelve months (TTM) ended in Apr. 2024 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Clearmind Medicine's gross profit for the three months ended in Apr. 2024 was $0.00 Mil. Clearmind Medicine's Revenue for the three months ended in Apr. 2024 was $0.00 Mil. Therefore, Clearmind Medicine's Gross Margin % for the quarter that ended in Apr. 2024 was N/A%.

Clearmind Medicine had a gross margin of N/A% for the quarter that ended in Apr. 2024 => No sustainable competitive advantage


Clearmind Medicine Gross Profit Historical Data

The historical data trend for Clearmind Medicine's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Gross Profit Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Gross Profit
Get a 7-Day Free Trial - - - - -

Clearmind Medicine Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Clearmind Medicine's Gross Profit

For the Biotechnology subindustry, Clearmind Medicine's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Gross Profit distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Gross Profit falls into.



Clearmind Medicine Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Clearmind Medicine's Gross Profit for the fiscal year that ended in Oct. 2023 is calculated as

Gross Profit (A: Oct. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Clearmind Medicine's Gross Profit for the quarter that ended in Apr. 2024 is calculated as

Gross Profit (Q: Apr. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Clearmind Medicine's Gross Margin % for the quarter that ended in Apr. 2024 is calculated as

Gross Margin % (Q: Apr. 2024 )=Gross Profit (Q: Apr. 2024 ) / Revenue (Q: Apr. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Clearmind Medicine  (NAS:CMND) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Clearmind Medicine had a gross margin of N/A% for the quarter that ended in Apr. 2024 => No sustainable competitive advantage


Clearmind Medicine Gross Profit Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (Clearmind Medicine) Headlines

From GuruFocus